JP2024525130A5 - - Google Patents

Info

Publication number
JP2024525130A5
JP2024525130A5 JP2023574821A JP2023574821A JP2024525130A5 JP 2024525130 A5 JP2024525130 A5 JP 2024525130A5 JP 2023574821 A JP2023574821 A JP 2023574821A JP 2023574821 A JP2023574821 A JP 2023574821A JP 2024525130 A5 JP2024525130 A5 JP 2024525130A5
Authority
JP
Japan
Prior art keywords
monoclonal antibody
amino acid
acid sequence
terminal amino
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023574821A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024525130A (ja
Filing date
Publication date
Priority claimed from GBGB2108802.6A external-priority patent/GB202108802D0/en
Application filed filed Critical
Publication of JP2024525130A publication Critical patent/JP2024525130A/ja
Publication of JP2024525130A5 publication Critical patent/JP2024525130A5/ja
Pending legal-status Critical Current

Links

JP2023574821A 2021-06-18 2022-06-17 Ｘｘ型コラーゲンのアッセイ Pending JP2024525130A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2108802.6 2021-06-18
GBGB2108802.6A GB202108802D0 (en) 2021-06-18 2021-06-18 Collagen type XX assay
PCT/EP2022/066635 WO2022263675A1 (en) 2021-06-18 2022-06-17 Collagen type xx assay

Publications (2)

Publication Number Publication Date
JP2024525130A JP2024525130A (ja) 2024-07-10
JP2024525130A5 true JP2024525130A5 (https=) 2025-06-13

Family

ID=77050621

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023574821A Pending JP2024525130A (ja) 2021-06-18 2022-06-17 Ｘｘ型コラーゲンのアッセイ

Country Status (7)

Country Link
US (1) US20240385191A1 (https=)
EP (1) EP4356137B1 (https=)
JP (1) JP2024525130A (https=)
KR (1) KR20240022470A (https=)
CN (1) CN117501123A (https=)
GB (1) GB202108802D0 (https=)
WO (1) WO2022263675A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011051278A1 (en) * 2009-10-26 2011-05-05 Externautics S.P.A. Lung tumor markers and methods of use thereof
CN108546760A (zh) * 2018-04-24 2018-09-18 郑州大学第附属医院 一种胰腺癌预后分子标志物非编码RNA Lnc-COL20A1-2及其应用

Similar Documents

Publication Publication Date Title
JP5021791B2 (ja) 診断目的のための生物学的液体における中間領域プロアドレノメデュリン部分領域の測定およびこのような測定を行うためのイムノアッセイ
JP6307509B2 (ja) 腎機能の診断若しくは監視又は腎機能障害の診断方法
JP6850254B2 (ja) 干渉を減少させるための方法
CN102869681B (zh) 嗜铬粒蛋白a的免疫测定法、抗体和试剂盒
CN103308673B (zh) 用于预测雌性对象中发生心血管事件的风险的方法
RU2019110953A (ru) Моноклональное антитело, специфически связывающееся с тиоредоксином-1, и его применение
CN103308689B (zh) 用于预测雌性对象中患上癌症的风险或诊断癌症的方法
CN104781672B (zh) 预测女性对象患癌症风险或诊断其癌症的方法
JP6088501B2 (ja) プレプロバソプレッシンまたはそのフラグメントへの結合物を得る方法
CN102753973B (zh) Ku86和其自身抗体的复合物的免疫测定方法、及其中使用的试剂盒
JP2024525130A5 (https=)
JPWO2009044561A1 (ja) 抗ｐｒｏＮＴ／ＮＭＮモノクローナル抗体
WO2007139099A1 (ja) 新規な酸化ｌｄｌ複合体及びその検知方法
CN103732627A (zh) 包含抗-atic自身免疫抗体的肝癌诊断标记物以及包含其抗原的肝癌诊断用组合物
JP2024542100A5 (https=)
JP2020514368A5 (https=)
CN116003594B (zh) 靶向cxcl4的抗体及其在抑郁障碍诊断中的用途
JP2020514369A5 (https=)
CN104937419A (zh) 预测受试者患癌症的风险或诊断癌症的方法
JP2024060569A (ja) 本態性高血圧症を検出するためのバイオマーカー、それを用いた検出方法及び検出試薬
WO2024124499A1 (zh) 靶向cxcl4的抗体及其在抑郁障碍诊断中的用途
WO2014177701A1 (en) Process for diagnosing a human subject with diseases affecting the kidneys, or at risk of acquiring diseases affecting the kidneys
JP2021092555A (ja) 動脈硬化病変の検出方法、検出試薬及び検出キット
RU2022106115A (ru) Эпитоп тиоредоксина-1 и моноклональное антитело, специфично связывающееся с ним
HK1212436B (en) A method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction